Amedeo Smart

Free Medical Literature Service

 

Amedeo

Irritable Bowel Syndrome
  Free Subscription

29.04.2024

1 Aging (Albany NY)
1 Auton Neurosci
1 Benef Microbes
1 Biomed Res Int
1 bioRxiv
1 BMC Gastroenterol
1 Cell Mol Gastroenterol Hepatol
1 Clin Exp Gastroenterol
2 Cureus
1 Dig Dis Sci
1 Dig Liver Dis
1 Eur J Nutr
1 Expert Opin Drug Metab Toxicol
1 Expert Opin Investig Drugs
1 FP Essent
1 Front Med (Lausanne)
1 Helminthologia
1 Int Immunopharmacol
1 Korean J Gastroenterol
2 Lancet Gastroenterol Hepatol
2 Medicine (Baltimore)
1 MMW Fortschr Med
2 Neurogastroenterol Motil
1 Nutrition
1 Rev Gastroenterol Mex (Engl Ed)
1 Sci Rep
1 Urology


    Aging (Albany NY)

  1. ZHANG J, Shi X, Wang Y
    Exploring causality in the association between gut microbiota and irritable bowel syndrome risk: a large Mendelian randomization study.
    Aging (Albany NY). 2024;16.
    >> Share


    Auton Neurosci

  2. WAEMONG A, Sattayachiti S, Cheaha D, Konthapakdee N, et al
    Effects of oral administration of ondansetron, a 5-HT(3) receptor antagonist, on anxiety-related behaviors and colonic hypercontractility in repeated stress-induced mice.
    Auton Neurosci. 2024;253:103178.
    >> Share


    Benef Microbes

  3. QING Q, Chen Y, Zheng DK, Sun ML, et al
    Systematic review with meta-analysis: effects of probiotic fungi on irritable bowel syndrome.
    Benef Microbes. 2023;14:303-315.
    >> Share


    Biomed Res Int

  4. JANATOLMAKAN M, Zobeiri M, Rezaeian S, Rostami S, et al
    Epidemiology of Celiac Disease in Western Iran during 2019-2021.
    Biomed Res Int. 2024;2024:1112812.
    >> Share


    bioRxiv

  5. ROBERTSON K, Hahn O, Robinson BG, Faruk AT, et al
    Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis.
    bioRxiv [Preprint]. 2024 Apr 12:2024.04.09.588619.
    >> Share


    BMC Gastroenterol

  6. SIA T, Tanaka RO, Mousad A, Narayan AP, et al
    Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2024;24:143.
    >> Share


    Cell Mol Gastroenterol Hepatol

  7. TAVARES LC, Lopera-Maya EA, Bonfiglio F, Zheng T, et al
    Rome III criteria capture higher irritable bowel syndrome SNP-heritability and highlight a novel genetic link with cardiovascular traits.
    Cell Mol Gastroenterol Hepatol. 2024 Apr 18:S2352-345X(24)00093.
    >> Share


    Clin Exp Gastroenterol

  8. TEIGE ES, Sortvik U, Lied GA
    A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.
    Clin Exp Gastroenterol. 2024;17:109-120.
    >> Share


    Cureus

  9. CHAUDHARY M, Midha NK, Sukhadiya P, Kumar D, et al
    Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years.
    Cureus. 2024;16:e56828.
    >> Share

  10. ALMASAUDI AS
    A Review of the Efficacy of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Managing Gastrointestinal Symptoms Related to Cancer Treatment.
    Cureus. 2024;16:e56579.
    >> Share


    Dig Dis Sci

  11. VALVERDE DE MORALES HG, Wang HL, Garber K, Corces V, et al
    Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08457.
    >> Share


    Dig Liver Dis

  12. TAGHADDOS D, Saqib Z, Bai X, Bercik P, et al
    Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment.
    Dig Liver Dis. 2024 Apr 22:S1590-8658(24)00309-8. doi: 10.1016/j.dld.2024.
    >> Share


    Eur J Nutr

  13. JANSSENDUIJGHUIJSEN L, van den Belt M, Rijnaarts I, Vos P, et al
    Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.
    Eur J Nutr. 2024 Apr 23. doi: 10.1007/s00394-024-03398.
    >> Share


    Expert Opin Drug Metab Toxicol

  14. MOZAFFARI S, Nikfar S, Abdollahi M
    Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new?
    Expert Opin Drug Metab Toxicol. 2024 Apr 26. doi: 10.1080/17425255.2024.2348488.
    >> Share


    Expert Opin Investig Drugs

  15. BASSOTTI G
    Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Expert Opin Investig Drugs. 2024 Apr 25:1-4. doi: 10.1080/13543784.2024.2347296.
    >> Share


    FP Essent

  16. CHENG C, England E
    Nutrition: Chronic Disease Management.
    FP Essent. 2024;539:23-34.
    >> Share


    Front Med (Lausanne)

  17. QUIROGA-CASTANEDA PP, Berrios-Villegas I, Valladares-Garrido D, Vera-Ponce VJ, et al
    Irritable Bowel Syndrome in medical students at a Peruvian university: a cross-sectional study.
    Front Med (Lausanne). 2024;11:1341809.
    >> Share


    Helminthologia

  18. BOUTAHAR M, Er-Rami M, Belaouni M
    Prevalence of Blastocystis sp. among cooks in the region of Fez-Meknes (Morocco).
    Helminthologia. 2023;60:36-43.
    >> Share


    Int Immunopharmacol

  19. NOZU T, Arie H, Miyagishi S, Ishioh M, et al
    Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
    Int Immunopharmacol. 2024;133:112099.
    >> Share


    Korean J Gastroenterol

  20. KIM HJ, Kim HJ
    [Bile Acid Diarrhea].
    Korean J Gastroenterol. 2024;83:133-142.
    >> Share


    Lancet Gastroenterol Hepatol

  21. NYBACKA S, Tornblom H, Josefsson A, Hreinsson JP, et al
    A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARBIS): a single-centre, single-blind, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00045.
    >> Share

  22. GHOSHAL UC, Mustafa U, Goenka MK
    Managing irritable bowel syndrome: balancing diet and pharmacotherapy.
    Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00113.
    >> Share


    Medicine (Baltimore)

  23. HOU Y, Chang X, Liu N, Wang Z, et al
    Different acupuncture and moxibustion therapies in the treatment of IBS-D with anxiety and depression: A network meta-analysis.
    Medicine (Baltimore). 2024;103:e37982.
    >> Share

  24. DING W, Chen L, Xia J, Dong G, et al
    Causal relationships between gut microbrome and digestive system diseases: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37735.
    >> Share


    MMW Fortschr Med

  25. WESTPHAL K
    [Not Available].
    MMW Fortschr Med. 2024;166:15-16.
    >> Share


    Neurogastroenterol Motil

  26. POKROTNIEKS J, Sitkin S
    He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 23:e14805. doi: 10.1111/nmo.14805.
    >> Share

  27. AHMED M, Pu A, Jencks K, Bishu S, et al
    Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.
    Neurogastroenterol Motil. 2024 Apr 23:e14809. doi: 10.1111/nmo.14809.
    >> Share


    Nutrition

  28. KNEZ E, Kadac-Czapska K, Grembecka M
    The importance of food quality, gut motility, and microbiome in SIBO development and treatment.
    Nutrition. 2024;124:112464.
    >> Share


    Rev Gastroenterol Mex (Engl Ed)

  29. GUIDO V, Pontet Y, Lopez V, Olano C, et al
    Prevalence of irritable bowel syndrome and other functional gastrointestinal disorders in Uruguay.
    Rev Gastroenterol Mex (Engl Ed). 2024 Apr 20:S2255-534X(24)00033.
    >> Share


    Sci Rep

  30. SARKAWI M, Raja Ali RA, Abdul Wahab N, Abdul Rathi ND, et al
    A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
    Sci Rep. 2024;14:9478.
    >> Share


    Urology

  31. KNOEDLER MA, Li S, Hirano S, Nakada SY, et al
    Higher Risk of Repeat Stone Surgery in Stone Formers with Concomitant Bowel Disease: Single Center Long Term Analysis.
    Urology. 2024 Apr 20:S0090-4295(24)00271-1. doi: 10.1016/j.urology.2024.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016